Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186652 · ClinicalTrials.gov registry record · Phase 1
PK Study With Pantoprazole in Obese Children and Adolescents
A Phase 1 study, sponsored by Phillip Brian Smith.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT02186652: Completed Phase 1 study, sponsored by Phillip Brian Smith.
NCT02186652 is a Phase 1 study that has completed, run by Phillip Brian Smith. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02186652, a Phase 1 study, has completed, sponsored by Phillip Brian Smith.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
Multicenter, comparative single-dose pharmacokinetic (PK) study
Interventions
- DRUG Pantoprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2014-06-04 |
| Est. Completion | 2015-09-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186652
The ClinicalTrials.gov registry entry for NCT02186652 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phillip Brian Smith, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pantoprazole is the first listed.
NCT02186652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186652 about?
NCT02186652 is a clinical study titled "PK Study With Pantoprazole in Obese Children and Adolescents". Multicenter, comparative single-dose pharmacokinetic (PK) study
What is the current status of trial NCT02186652?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2014-06-04. Estimated completion is 2015-09-13.
What interventions are being tested in trial NCT02186652?
The interventions under investigation include: Pantoprazole (DRUG).
Who is sponsoring clinical trial NCT02186652?
This trial is sponsored by Phillip Brian Smith, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.